Abstract
Purpose
To examine the association of physical activity (PA) with bone health among patients with breast cancer receiving adjuvant aromatase inhibitor (AI) treatment.
Methods
In this single-center observational study, we enrolled postmenopausal women with primary hormone receptor-positive breast cancer who were receiving adjuvant AI treatment. We assessed patient bone health [bone mineral density (BMD) and biomarkers of bone turnover] as main outcomes. PA was assessed using Baecke physical activity questionnaires (BPAQ) and an accelerometer. Multiple regression analysis was performed after adjustment for age, body mass index, smoking history and duration of AI treatment. For missing data, multiple imputation analysis was adapted.
Results
The mean age of the 53 enrolled patients was 67.4 ± 8.4 years. The mean duration of AI administration was 25.7 ± 18.9 months. The most frequently administered AI was anastrozole (73.6%). Although not related to BMD, PA was related to bone turnover. Serum collagen type I amino-terminal propeptide, a bone formation marker, was associated with only light PA (t = − 2.55, p = 0.015), while tartrate-resistant acid phosphatase 5b, a bone absorption marker, was associated with work index in the BPAQ subscale and light PA (t = − 2.28, p = 0.028, t = − 2.26, p = 0.031, respectively). The results for all patients were similar to those observed in the multiple imputation analysis.
Conclusion
PA was significantly associated with bone turnover among cancer patients receiving AI treatment. Light PA and PA in the work domain were the most important factors among various PA intensities and PA domains.
Similar content being viewed by others
Data availability
The study protocol that approved by the Ethics Committee of the Kobe University Graduate School of Health Sciences was not allowed to share any outside with the dataset.
Abbreviations
- LC:
-
Lifecorder
- PINP:
-
Collagen type I amino-terminal propeptide
- TRACP-5b:
-
Tartrate-resistant acid phosphatase 5b
- PA:
-
Physical activity
- DXA:
-
Dual energy X-ray absorptiometry
- AI:
-
Aromatase inhibitor
- BPAQ:
-
Baecke physical activity questionnaires
- VPA:
-
Vigorous physical activity
- MPA:
-
Moderate physical activity
- LPA:
-
Light physical activity
- SB:
-
Sedentary behaviour
- MET:
-
Metabolic equivalents
References
Howell A, Cuzick J, Baum M et al (2005) Results of the ATAC (arimidex, tamoxifen, alone or in combination) trial after completion of 5 years' adjuvant treatment for breast cancer. Lancet 365(9453):60–62
Coombes RC, Hall E, Gibson LJ et al (2004) A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer. N Engl J Med 350(11):1081–1092
Thurlimann B, Keshaviah A, Coates AS et al (2005) A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer. N Engl J Med 353(26):2747–2757
Coleman RE, Banks LM, Girgis SI et al (2007) Skeletal effects of exemestane on bone-mineral density, bone biomarkers, and fracture incidence in postmenopausal women with early breast cancer participating in the intergroup exemestane study (IES): a randomized controlled study. Lancet Oncol 8(2):119–127
Coates AS, Keshaviah A, Thurlimann B et al (2007) Five years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer: update of study BIG 1–98. J Clin Oncol 25(5):486–492
Eastell R, Adams JE, Coleman RE et al (2008) Effect of anastrozole on bone mineral density: 5-year results from the anastrozole, tamoxifen, alone or in combination trial 18233230. J Clin Oncol 26(7):1051–1057
Perez EA, Josse RG, Pritchard KI et al (2006) Effect of letrozole versus placebo on bone mineral density in women with primary breast cancer completing 5 or more years of adjuvant tamoxifen: a companion study to NCIC CTG MA.17. J Clin Oncol 24(22):3629–3635
Hillner BE, Ingle JN, Chlebowski RT et al (2003) American Society of Clinical Oncology 2003 update on the role of bisphosphonates and bone health issues in women with breast cancer. J Clin Oncol 21(21):4042–4057
Zerwekh JE, Ruml LA, Gottschalk F et al (1998) The effects of twelve weeks of bed rest on bone histology, biochemical markers of bone turnover, and calcium homeostasis in eleven normal subjects. J Bone Miner Res 13(10):1594–1601
Chastin SF, Mandrichenko O, Helbostadt JL et al (2014) Associations between objectively-measured sedentary behavior and physical activity with bone mineral density in adults and older adults, the NHANES study. Bone 64:254–262
Thomas GA, Cartmel B, Harrigan M et al (2017) The effect of exercise on body composition and bone mineral density in breast cancer survivors taking aromatase inhibitors. Obesity (Silver Spring) 25(2):346–351
Schwartz AL, Winters-Stone K, Gallucci B (2007) Exercise effects on bone mineral density in women with breast cancer receiving adjuvant chemotherapy. Oncol Nurs Forum 34(3):627–633
Lynch BM, Dunstan DW, Healy GN et al (2010) Objectively measured physical activity and sedentary time of breast cancer survivors, and associations with adiposity: findings from NHANES (2003–2006). Cancer Causes Control 21(2):283–288
Kampshoff CS, Jansen F, van Mechelen W et al (2014) Determinants of exercise adherence and maintenance among cancer survivors: a systematic review. Int J Behav Nutr Phys Act 11:80
Luchavova M, Zikan V, Michalska D et al (2011) The effect of timing of teriparatide treatment on the circadian rhythm of bone turnover in postmenopausal osteoporosis. Eur J Endocrinol 164(4):643–648
Yamada S, Inaba M, Kurajoh M et al (2008) Utility of serum tartrate-resistant acid phosphatase (TRACP5b) as a bone resorption marker in patients with chronic kidney disease: independence from renal dysfunction. Clin Endocrinol (Oxf) 69(2):189–196
Ono R, Hirata S, Yamada M et al (2007) Reliability and validity of the Baecke physical activity questionnaire in adult women with hip disorders. BMC Musculoskelet Disord 8:61
Baecke JA, Burema J, Frijters JE (1982) A short questionnaire for the measurement of habitual physical activity in epidemiological studies. Am J Clin Nutr 36(5):936–942
Masse LC, Fuemmeler BF, Anderson CB et al (2005) Accelerometer data reduction: a comparison of four reduction algorithms on select outcome variables. Med Sci Sports Exerc 37(11 Suppl):S544–554
Ayabe M, Kumahara H, Morimura K et al (2013) Epoch length and the physical activity bout analysis: an accelerometry research issue. BMC Res Notes 6:20
Kumahara H, Schutz Y, Ayabe M et al (2004) The use of uniaxial accelerometry for the assessment of physical-activity-related energy expenditure: a validation study against whole-body indirect calorimetry. Br J Nutr 91(2):235–243
Ainsworth BE, Haskell WL, Herrmann SD et al (2011) 2011 Compendium of physical activities: a second update of codes and MET values. Med Sci Sports Exerc 43(8):1575–1581
Pate RR, O'Neill JR, Lobelo F (2008) The evolving definition of "sedentary". Exerc Sport Sci Rev 36(4):173–178
Ishii M, Uenishi K, Ishida Y et al (2005) Development of the “Self-assessment Table for Calcium Intake” and Evaluation of Its Validity. Osteoporo Jpn 13(2):221–226 (in Japanese)
Uenishi K, Ishida Y, Kamao M et al (2011) Development and evaluation of simple vitamin K intake questionnaire. Osteoporo Jpn 19(3):195–200 (in Japanese)
Royston P (2009) Multiple imputation of missing values: further update of ice, with an emphasis on categorical variables. Stata J 9(3):466
White IR, Royston P, Wood AM (2011) Multiple imputation using chained equations: issues and guidance for practice. Stat Med 30(4):377–399
Theiler R, Stahelin HB, Kranzlin M et al (1999) High bone turnover in the elderly. Arch Phys Med Rehabil 80(5):485–489
Kemmler W, Weineck J, Kalender WA et al (2004) The effect of habitual physical activity, non-athletic exercise, muscle strength, and VO2max on bone mineral density is rather low in early postmenopausal osteopenic women. J Musculoskelet Neuronal Interact 4(3):325–334
Brooke-Wavell K, Jones PR, Hardman AE et al (2001) Commencing, continuing and stopping brisk walking: effects on bone mineral density, quantitative ultrasound of bone and markers of bone metabolism in postmenopausal women. Osteoporos Int 12(7):581–587
Thorsen K, Kristoffersson A, Lorentzon R (1996) The effects of brisk walking on markers of bone and calcium metabolism in postmenopausal women. Calcif Tissue Int 58(4):221–225
Pruitt LA, Taaffe DR, Marcus R (1995) Effects of a one-year high-intensity versus low-intensity resistance training program on bone mineral density in older women. J Bone Miner Res 10(11):1788–1795
Sritara C, Thakkinstian A, Ongphiphadhanakul B et al (2015) Work- and travel-related physical activity and alcohol consumption: relationship with bone mineral density and calcaneal quantitative ultrasonometry. J Clin Densitom 18(1):37–43
Blanchet C, Giguere Y, Prud'homme D et al (2003) Leisure physical activity is associated with quantitative ultrasound measurements independently of bone mineral density in postmenopausal women. Calcif Tissue Int 73(4):339–349
Ainsworth BE, Haskell WL, Whitt MC et al (2000) Compendium of physical activities: an update of activity codes and MET intensities. Med Sci Sports Exerc 32(9 Suppl):S498–504
Acknowledgements
The authors are extremely grateful to the patients who participated in this study and all the staff members of the Department of Breast Surgery at Kobe University Hospital.
Author information
Authors and Affiliations
Contributions
TS: Conceptualization, Methodology, Formal Analysis, Visualization, Writing (Original Draft), and Investigation. RO: Conceptualization, Writing (Review and Editing), Visualization, and Project Administration. SK: Conceptualization and Resources. MA: Conceptualization, Methodology, Formal Analysis, and Investigation. AF: Investigation. YT: Methodology and Resources. ST: Resources. YS: Methodology and Supervision.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
The present study was performed in accordance with the tenets of the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The study protocol was approved by the Ethics Committee of the Kobe University Graduate School of Health Sciences.
Research involving human and animal participants
This article does not contain any studies with animals performed by any of the authors.
Informed consent
All patients were informed of the study protocol and signed an informed consent form before assessment.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Saito, T., Ono, R., Kono, S. et al. Physical activity among patients with breast cancer receiving aromatase inhibitors is associated with bone health: a cross-sectional observational study. Breast Cancer Res Treat 182, 187–193 (2020). https://doi.org/10.1007/s10549-020-05668-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10549-020-05668-5